3 young patients redofer from mpox in Cabanatuan City

ɫTV

3 young patients recover from mpox in Cabanatuan City

By: - Correspondent /
/ 02:07 PM June 03, 2025

3 young patients recover from mpox in Cabanatuan City

INQUIRER FILES

CABANATUAN CITY, Philippines — Three school-aged children in this city tested positive for mpox (formerly known as monkeypox) but have since fully recovered, a local health official confirmed Monday.

Edwin Manabat, head of the City Epidemiology and Surveillance Unit (CESU), said the patients — two boys and a girl, all aged 15 or younger — no longer show symptoms.

Article continues after this advertisement

“Their lesions have completely dried up, which is a clear sign of full recovery,” Manabat said.

FEATURED STORIES

READ: Baybay City issues order to prevent possible entry of mpox

The first case was reported in March, followed by the second in April and the third in May.

Manabat said family members of the infected children were placed under strict monitoring but all tested negative for the virus.

He added that the patients live in different barangays, have no known connection to one another, and did not have any recent travel history.

Article continues after this advertisement

Laboratory tests by the Research Institute for Tropical Medicine confirmed the children were infected with the less severe Clade II strain of the mpox virus.

While the cases are considered isolated, Manabat urged the public to maintain proper hygiene as a preventive measure.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

TAGS: Cabanatuan City, mpox

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2025 ɫTV | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.